glp 1 medications side effects GLP-1 nausea: How to handle GLP-1s' most common effect The GLP-1 Agonists and Obesity:
Description
This is the reason for the contraindications in the previous section
In the Standards of Medical Care in Diabetes2021, the ADA recommend that for people with indications of high risk or established CKD either a sodium-glucose co-transporter-2 inhibitor (SGLT2i) or a glucagon-like peptide-1 receptor agonist (GLP-1 RA) be considered as a treatment option, independently of metformin use [15]
Rocha M, Diaz-Morales N, Rovira-Llopis S, et al
[DOI] [PubMed] [Google Scholar] 79.NamKoong C, Kim MS, Jang BT, et al
